ArticlePDF Available

The Effect of Oral Feeding of Tribulus terrestris L. on Sex Hormone and Gonadotropin Levels in Addicted Male Rats

Authors:
  • medical university Mashhad Iran

Abstract and Figures

Background: Opioids can exert adverse effects on the body. Morphine, an opioid drug, reduces hormone levels and fertility, and causes sexual activity disorders. Tribulus terrestris (TT) is a traditional herbal medicine used to enhance sexual activities. This study investigates the possible role of TT on sex hormones and gonadotropins with the intent to show its usefulness in treating fertility disorders in opioid users. Materials and methods: In this experimental study, we randomly divided 48 rats into four groups: i. control, ii. TT-treated, iii. addicted and iv. TT-treated addicted. Watersoluble morphine was administrated orally for 21 days to induce addiction, after which the treated groups 2 and 4 received plant-mixed pelleted food (6.25%) orally for four weeks. At the end of the treatment period, the sex hormone and gonadotropin levels of all rats' sera were determined by radioimmunoassay and Elisa kits. The data obtained were statistically analyzed using the one-way analysis of variance, followed by post-hoc Tukey test. P<0.05 was considered significant. Results: The addicted group had a significantly lower luteinizing hormone (LH) level than the control group (p<0.027). LH levels increased significantly in the TT-treated addicted group (p<0.031). The testosterone level in the treated addicted group was lower than the treated control group. The addicted group had a significantly low testosterone level (p<0.001). The estrogen level was significantly (p<0.002) lower in the addicted group than in the control group. In addition, there was a significant difference between the treated addicted group and the treated control group (p<0.048). The treated control group had a significant increase in its progesterone level (p<0.002). Overall, except for follicle-stimulating hormone (FSH), morphine reduced most of the gonadotropins and sexual hormones. Whereas TT caused a considerable increase (p<0.05) in the hormones in the treated addicted group, there was only a slight increase in the treated control group. Conclusion: Oral consumption of TT could markedly antagonize the reduction of sex hormones and gonadotropins (except for FSH) due to morphine addiction.
Content may be subject to copyright.
57
Original Article
The Eect of Oral Feeding of
Tribulus terrestris L.
on Sex
Hormone and Gonadotropin Levels in Addicted Male Rats
Mohammad Hassan Ghosian Moghaddam, Ph.D.
1
, Mohsen Khalili, Ph.D.
2
,
Maryam Maleki, M.D.
3
*, Mohammad Esmail Ahmad Abadi, M.D.
3
1. Department of Biochemistry, Shahed University, Tehran, Iran
2. Neurophysiology Research Center, Shahed University, Tehran, Iran
3. Shahed University, Tehran, Iran
Abstract
Background: Opioids can exert adverse effects on the body. Morphine, an opioid drug,
reduces hormone levels and fertility, and causes sexual activity disorders. Tribulus ter-
restris (TT) is a traditional herbal medicine used to enhance sexual activities. This study
investigates the possible role of TT on sex hormones and gonadotropins with the intent to
show its usefulness in treating fertility disorders in opioid users.
Materials and Methods: In this experimental study, we randomly divided 48 rats into
four groups: i. control, ii. TT-treated, iii. addicted and iv. TT-treated addicted. Water-
soluble morphine was administrated orally for 21 days to induce addiction, after which
the treated groups 2 and 4 received plant-mixed pelleted food (6.25%) orally for four
weeks. At the end of the treatment period, the sex hormone and gonadotropin levels of all
rats’ sera were determined by radioimmunoassay and Elisa kits. The data obtained were
statistically analyzed using the one-way analysis of variance, followed by post-hoc Tukey
test. P<0.05 was considered signicant.
Results: The addicted group had a signicantly lower luteinizing hormone (LH) level
than the control group (p<0.027). LH levels increased signicantly in the TT-treated ad-
dicted group (p<0.031). The testosterone level in the treated addicted group was lower
than the treated control group. The addicted group had a signicantly low testosterone
level (p<0.001). The estrogen level was signicantly (p<0.002) lower in the addicted
group than in the control group. In addition, there was a signicant difference between
the treated addicted group and the treated control group (p<0.048). The treated control
group had a signicant increase in its progesterone level (p<0.002). Overall, except for
follicle-stimulating hormone (FSH), morphine reduced most of the gonadotropins and
sexual hormones. Whereas TT caused a considerable increase (p<0.05) in the hormones
in the treated addicted group, there was only a slight increase in the treated control group.
Conclusion: Oral consumption of TT could markedly antagonize the reduction of sex
hormones and gonadotropins (except for FSH) due to morphine addiction.
Keywords: Morphine, Tribulus terrestris, FSH, LH, Sex Hormones
Citation: Ghosian Moghaddam MH, Khalili M, Maleki M, Ahmad Abadi ME. The effect of oral feeding of tribulus ter-
restris L. on sex hormone and gonadotropin levels in addicted male rats. Int J Fertil Steril. 2013; 7(1): 57-62.
Received: 25 Dec 2011, Accepted: 13 Oct 2012
* Corresponding Address: P.O.Box: 141557435, Shahed
University, Tehran, Iran
Email: mlk.mry@gmail.com
Royan Institute
International Journal of Fertility and Sterility
Vol 7, No 1, Apr-Jun 2013, Pages: 57-62
Introduction
Recent years have witnessed a dramatic rise in
the use of opioid drugs despite the documentation
of their numerous adverse effects in the literature.
One of these side effects is the negative impact on
sex hormone levels, libido, potency, and menor-
rhea (1-3). A study has shown that 96% of men
and 69% of women who receive opioid analgesic
IJFS, Vol 7, No 1, Apr-Jun 2013
58
drugs for pain management have decreased libido
or impotency (4). Also, it has been found that spi-
nal opiate analgesics reduce libido and cause dif-
culty in achieving or maintaining an erection in
men (5).
One of the most commonly used opioid drugs
is morphine. In a prospective, uncontrolled,
non-randomized study, a group of men with an
average pain duration of 11 years used intrathe-
cal morphine for 12 weeks. Most of the patients
reported poor libido and erectile difficulty to-
ward the end of the 12-week period; in addition,
testosterone and follicle-stimulating hormone
(FSH) levels significantly reduced. The intrath-
ecal opioid caused a reduction in hormone lev-
els (6).
Tribulus terrestris (TT), commonly known as
caltrop or devil’s eyelashes plays an important role
in traditional medicine. Most parts of this plant
are used in herbal medicine, for which TT can en-
hance sex drive and treat urolithiasis, menorrha-
gia, impotency, rheumatism pains, and premature
ejaculation (7-9). Khordadmehr and his colleagues
have used TT in an herbal formula, NOFODA, to
investigate its effect on infertile males and con-
cluded that it improved both sperm motility and
count (10).
In studies conducted on animals, TT is thought
to have a luteinizing hormone (LH)-like activity,
which can induce corpus luteum formation in fe-
male rats (11). LH induces the corpus luteum to
secrete progesterone. This results in an increase
in progesterone levels as well as some estrogen
secretion. Studies have shown that protodioscin,
which is found in TT extract, treats mild to mod-
erate erectile dysfunction and increases libido
(12, 13).
In light of the increasing fertility disorders in
opioid users, the present study investigated the ef-
fect of TT on the sex hormones and gonadotropins
of addicted male rats.
Materials and Methods
Experimental animals
Adult male Wister rats that weighed 200 ± 25 g
each (Razi Institute, Iran) were randomly divided
into four groups, of 12 animals each: i. control,
ii. TT-treated, iii. addicted and iv. TT-treated ad-
Ghosian Moghaddam et al.
dicted. The rats were housed in groups of three in
cages at a temperature of 22-25˚C, on a 12 hour
light/12 hour dark schedule and sufcient amounts
of food and water.
Preparation of Tribulus terrestris (TT)
After obtaining TT and verifying its suitability
for our study via the Department of Botany at Sha-
hid Beheshti University, we ground and combined
the plant with pelleted food at a weight ratio of
6.25%.
Study protocol
Morphine addiction was induced according to
the method of Moini Zanjani et al. (14). Groups
3 and 4 received oral administrations of water-
soluble morphine for 21 days. During this 21-day
period, the treated groups (2 and 4) also received
oral administration of TT plant-mixed pelleted
food (6.25%).
The water soluble morphine solution was given
in doses of 0.1, 0.2, and 0.3 mg/ml according to
the method of Swanston-Flatt et al. (15); each of
these doses was administered for 48 hours for the
rats to drink and then 0.4 mg/ml was administered
for the remaining 15 days. The bitterness of mor-
phine was eliminated by adding 3% sucrose to the
solution. In this experiment, the average amount
of water consumed, and therefore morphine, by
rats was approximately 60-80 mg/ml/day. Addic-
tion was conrmed by injecting a morphine an-
tagonist (naloxone) and observing for withdrawal
symptoms.
All techniques and methods were approved by
the Ethics Committee of Shahed University of
Medical Sciences. The laboratory animals were af-
forded due care in accordance with the regulations
of the Committee for the Purpose of Control and
Supervision on Experiments on Animals (CPC-
SEA).
Blood sampling
After 21 days of treatment, at treatment termi-
nation, blood samples (3-5cc) were obtained from
all the rats’ hearts to measure hormone levels. The
sera were subsequently separated via centrifuge
(Sigma 4-10, USA) at 2000 rpm for 10 minutes
and stored at -70˚C in a freezer until hormone
analysis.
59
The Effect of
Tribulus terrestris
on Hormone Levels
Plasma analysis
The plasma concentrations of the sex hormones
and gonadotropins were veried by the radioim-
munoassay (RIA) method using kits manufactured
by Monobind Inc. (USA), as well as ELISA kits
(Labsystem, Finland).
Statistical analysis
Obtained data were expressed as mean ± SEM
and statistically analyzed using the one-way analy-
sis of variance (ANOVA), followed by the post-
hoc Tukey test. p<0.05 was considered statistically
signicant.
Results
FSH analysis
Our FSH analysis showed that the TT-treated
control group had the least amount of FSH (0.271
± 0.025 mIU/ml), while the morphine-addicted
group had the highest FSH level (0.348 ± 0.022
mIU/ml). Morphine solely did not suppress FSH.
The TT-treated addicted group had a higher FSH
level (0.302 ± 0.01 mIU/ml) than did the TT-treat-
ed control group; there was, however, no signi-
cant change in any of the groups. Figure 1 illus-
trates these results.
FSH (mlU/ml)
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
Control Con+TT Morphine Mor+TT
Test groups
Fig 1: The effect of Tribulus terrestris (TT) on FSH levels
in control and addicted groups. Bars depict mean ± SEM
of LH.
LH analysis
In LH analysis, the addicted group had decreased
LH levels. The highest amount of LH belonged to
the treated control group (0.207 ± 0.098 mIU/ml).
Figure 2 shows a signicantly lower LH level in
the addicted group than the control group (0.0125
± 0.017 mIU/ml), which was due to morphine sup-
pression (p<0.027). The TT-treated addicted group
had a signicantly higher amount of LH (0.273 ±
0.066 mIU/ml) than did the control group p<0.031.
LH (mlU/ml)
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
Control Con+TT Morphine Mor+TT
Test groups
*
$
Fig 2: The effect of Tribulus terrestris (TT) on LH levels
in control and addicted groups. Bars depict mean ± SEM
of LH.* and $; P<0.05 compared between the control and
treated control groups.
Testosterone analysis
In this analysis, there was a reduction in the
addicted group (0.122 ± 0.058 ng/ml). The high-
est amount of testosterone belonged to the con-
trol group (0.399 ± 0.04 ng/ml). Figure 3 shows
that the addicted group had the least amount of
testosterone, as a result of morphine suppres-
sion. The treated addicted group had a signifi-
cantly lower hormone level (p<0.024) than did
the treated control group (0.193 ± 0.057 ng/ml).
The addicted group had a significantly lower
testosterone level than did the control group
(p<0.001).
Testestrone (ng/ml)
0.5
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
Control Con+TT Morphine Mor+TT
Test groups
*
*
Fig 3: The effect of Tribulus terrestris (TT) on testosterone
levels in control and addicted groups.
Bars depict mean ± SEM of testosterone. *; P<0.05 com-
pared between the control and treated control groups.
Estrogen analysis
Our estrogen analysis revealed a decrease in
the addicted group compared to the control group
(22.70 ± 3.21 pg/ml). Figure 4 illustrates these
IJFS, Vol 7, No 1, Apr-Jun 2013
60
results. Compared to the control group, estro-
gen decreased in the addicted group; there was a
signicant difference between these two groups
(p<0.002). Figure 4 also shows a signicant dif-
ference between the treated addicted group and the
treated control group (p<0.048).
Estrogen (pg/ml)
60
50
40
30
20
10
0
Control Con+TT Morphine Mor+TT
Test groups
*
$
Fig 4: The effect of Tribulus terrestris (TT) on estrogen levels in
control and addicted groups. Bars depict mean ± SEM of LH.
* and $; P<0.05 compared between the control and treated
control groups.
Progesterone analysis
There was an increase in the treated control
group and a decrease in the addicted group
according to progesterone analysis. Figure 5
shows that the treated control group had the
highest hormone level (79.28 ± 5.2 pg/ml),
which was due to TT. The addicted group had
the least amount, which was due to the effects
of morphine. The addicted group had a lower
progesterone level than did the control group;
the difference, however, was not significant. In
comparison with the treated addicted group, the
treated control group had a significant increase
in hormone levels (p<0.002).
Progesterone (pg/ml)
90
80
70
60
50
40
30
20
10
0
Control Con+TT Morphine Mor+TT
Test groups
*
Fig 5: The effect of Tribulus terrestris (TT) on progesterone
levels in the control and addicted groups. Bars depict mean
± SEM of progesterone.
*; P<0.05 compared between the control and treated control
groups.
Discussion
In this study, sex hormone and gonadotropin
levels were evaluated based on the effect of TT
on morphine-addicted rats. FSH, a stimulating
hormone of the ovarian follicles, had a higher
level in our morphine-addicted groups. In the
treated morphine group, the FSH level had the
most decrease, which demonstrated that TT
suppressed FSH release in the addicted rats. A
similar result was observed in the treated con-
trol group; however the difference was not sig-
nificant.
Tabakova and his colleagues, in a compari-
son of endocrinal functions before and after
TT therapy, reported that TT acted on the hy-
pothalamus and reduced FSH levels but did not
decrease ovarian hormones (estrogen and pro-
gesterone). They concluded that TT could be
used to treat menopausal symptoms such as hot
flashes and increase sex drive. These research-
ers speculated that the presence of saponin in
TT was responsible for FSH suppression and
the resultant alleviation of hot flashes, irritabil-
ity, and depression in menopausal women (16).
However, in our study, no significant effect of
TT on FSH levels was found.
We observed a signicant decrease in LH lev-
els in the morphine-addicted group. The treated
addicted group had a relatively higher LH than
did the addicted group, which denoted that TT in-
creased LH levels. Similarly, the treated control
group had a signicantly higher LH level than did
the control group.
According to Neychev et al. (17) and a study
by Antonio et al. it was shown that TT induced
LH release. The upswing in LH led to a signal
for testosterone to increase (18). With regard to
testosterone levels, there was a significant de-
crease in our addicted rats. In the treated ad-
dicted group, the level was significantly higher
than that of the addicted group. Although TT
affected the increase in testosterone, a num-
ber of studies have demonstrated different re-
sults. Studies demonstrated that TT caused an
increase in testosterone, increase in cavernous
body pressure, increase in systolic pressure, and
increase in penile erection (19-22). In addition,
the effect of TT on castrated rats compared to
Ghosian Moghaddam et al.
61
normal rats was an increase in prostate weight,
which augmented sexual activities and potency
(22). In contrast, Neychev and his colleague re-
ported that TT did not influence androgen lev-
els in young men (17). Our results support the
results of a majority of similar studies in the
literature.
Based on our study, estrogen decreased sig-
nificantly in the addicted group but increased
significantly in the treated addicted group. It
can, therefore, be concluded that TT signifi-
cantly increased the estrogen hormone level in
male addicted rats. Of note, there was a dearth
of specic studies on estrogen in the literature.
Progesterone decreased in our addicted group;
the amount, however, was insignificant. In con-
trast, progesterone significantly increased in
the treated control group. We concluded that TT
increased progesterone in non-addicted cases;
however this increase was not significant in ad-
dicted cases. Mazaro-Costa and colleagues have
reported that not only could TT treat sexual dis-
orders and dysfunction in menopausal women
but it could also enhance vasomotor actions.
There are, however, no reports on progesterone
specifically (19).
Conclusion
The present study shows that addiction decreas-
es sex hormones and gonadotropins. Treatment
with TT can increase the hormone levels of tes-
tosterone, progesterone, estrogen, and LH. Never-
theless, TT did not increase the FSH levels in our
male rats.
Acknowledgments
This paper is the result of a medical student
thesis and was financially supported by the
Research Council of Shahed University. The
authors declare that they have no conflicts of
interest.
References
1. Winkelmuller M, Winkelmuller W. Long-term effects
of
continuous intrathecal opioid treatment in chronic
pain of nonmalignant etiology. J Neurosurg. 1996;
85(3): 458-467.
2. Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT.
Hypogonadism in patients treated with intrathecal mor-
phine. Clin J Pain. 2000; 16(3): 251-254.
3. Roberts LJ, Finch PM, Goucke CR, Price LM. Out-
come of intrathecal opioids in chronic non-cancer
pain. Eur J Pain. 2001; 5(4): 353-361.
4. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Op-
somer F, Adriaensen H, et al. Endocrine consequenc-
es of long-term intrathecal administration of opioids. J
Clin Endocrinol Metab. 2000; 85(6): 2215-2222.
5. Paice JA, Penn RD, Ryan WG. Altered sexual func-
tion and decreased testosterone in patients receiving
intraspinal opioids. J Pain Symptom Manage. 1994;
9(2): 126-131.
6. Roberts LJ, Finch PM, Pullan PT, Bhagat CI, Price
LM. Sex hormone suppression by intrathecal opioids:
a prospective study. Clin J Pain. 2002; 18(3): 144-
148.
7. Gauthaman K, Adaikan PG, Prasad RN. Aphrodisiac
properties of Tribulus Terrestris extract (Protodioscin)
in normal and castrated rats. Life Sciences. 2002; 71
(12): 1385-1396.
8. Al-Ali M, Wahbi S, Twaij H, Al-Badr A. Tribulus ter-
restris: preliminary study of its diuretic and contractile
effects and comparison with Zea mays. J Ethnophar-
macol. 2003; 85 (2-3): 257-260.
9. Selvam ABD. Inventory of Vegetable Crude Drug
samples housed in Botanical Survey of India, How-
rah. Pharmacog Rev. 2008; 2(3): 61-94.
10. Khoradmehr A , Khalili MA , Ramezani M , Adib M ,
Vahidi S , Moin MR. Effects of Herbal Drug NOFODA
onSperm Parameters of Infertile Men. Int J Fertil Ster-
il. 2010; 4 Suppl 1: P12.
11. Esfandiari A, Dehghan A, Sharifi S, Najafi B, Vesali
E. Effect of tribulus terrestris extract on ovarian activ-
ity in immature Wistar rat: a histological evaluation. J
Anim Vet Adv. 2011; 10(7): 883-886.
12. Gauthaman K, Ganesan AP. The hormonal effects
of Tribulus terrestris and its role in the management
of male erectile dysfunction- anevaluation using pri-
mates, rabbit and rat. Phytomedicine 2008, 15 (1-2):
44-54.
13. Frydrychová S, Opletal L, Macáková K, Lustyková A,
Rozkot M, Lipenský J. Effects of herbal preparation
on libido and semen quality in boars. Reprod Domest
Anim. 2011, 46(4): 573-578.
14. Moini Zanjani T, Sabetkasaei M. Study of the intra-
plantar injection of lidocaine and morphine on pain
perception and the influence of morphine depend-
ence and withdrawal on lidocaine-induced analgesia
in rats. Iran Biomed J. 2010; 14(4): 164-170.
15. Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR. Evalu-
ation of traditional plant treatments for diabetes: stud-
ies in streptozotocin diabetic mice. Acta Diabetol Lat.
1989; 26(1): 51-55.
16. Tabakova P, Dimitrov M, Tashkov B. Kirkoua-Sofia
Clinical studies on the preparation tribestan in women
with endocrine infertility or menopausal syndrome.
(1984-1987) Available from:http://www.scicompdf.se/
tiggarnot/tabakova-HerbPharmUSA.pdf.(8 Oct 2012).
17. Neychev VK, Mitev VI. The aphrodisiac herb Tribulus
terrestris does not influence the androgen production
in young men. J Ethnopharmacol. 2005, 101(1-3):
319-323.
18. Antonio J, Uelmen J, Rodriguez R, Earnest C. The
effects of Tribulus terrestris on body composition and
exercise performance in resistance-trained males. Int
The Effect of
Tribulus terrestris
on Hormone Levels
IJFS, Vol 7, No 1, Apr-Jun 2013
62
J Sport Nutr Exerc Metab. 2000; 10(2): 208-215.
19. Mazaro-Costa R, Andersen M L, Hachul H, Tufik S.
Medicinal plants as alternative treatments for female
sexual dysfunction: utopian vision or possible treatment
in climacteric women? J Sex Med. 2010; 7(11): 3695-
3714.
20. El-Tantawy WH, Temraz A, El-Gindi OD. Free serum tes-
tosterone level in male rats treated with Tribulus alatus
extracts. Int Braz J Urol. 2007; 33(4): 554-559.
21. Park SW, Lee CH, Shin DH, Bang NS, Lee SM. Effect of
SA1, a herbal formulation, on sexual behavior and penile
erection. Biol Pharm Bull. 2006; 29(7): 1383-1386.
22. Gauthaman K, Adaikan PG, Prasad RN. Aphrodisiac prop-
erties of Tribulus Terrestris extract (Protodioscin) in normal
and castrated rats. Life Sci. 2002; 71(12): 1385-1396.
Ghosian Moghaddam et al.
... The shortlisted studies included five human clinical trials evaluating the therapeutic effect [10,25,27,33,34], of which two were randomized trials [25,27] and three were nonrandomized trials [10,33,34]. Five animal studies evaluated the preventive effect of TT against various fertility-compromising agents [35][36][37][38][39], ten evaluated the therapeutic effect of TT in model organisms [9,11,15,18,[40][41][42][43][44][45], and eighteen studies administered TT in normal animals to evaluate improvements in semen parameters, hormone levels, and its aphrodisiac effect [9,16,17,20,36,37,39,40,42,43,[45][46][47][48][49][50][51][52] (Table 2). ...
... The shortlisted studies included five human clinical trials evaluating the therapeutic effect [10,25,27,33,34], of which two were randomized trials [25,27] and three were nonrandomized trials [10,33,34]. Five animal studies evaluated the preventive effect of TT against various fertility-compromising agents [35][36][37][38][39], ten evaluated the therapeutic effect of TT in model organisms [9,11,15,18,[40][41][42][43][44][45], and eighteen studies administered TT in normal animals to evaluate improvements in semen parameters, hormone levels, and its aphrodisiac effect [9,16,17,20,36,37,39,40,42,43,[45][46][47][48][49][50][51][52] (Table 2). ...
... TT in these studies was administered either afterwards to evaluate the therapeutic effect or along with the method of model creation to investigate the prophylactic effect. Nine studies with seventeen datasets had administered TT in therapeutic mode in animal models of infertility generated by various means [9,11,18,[40][41][42][43][44][45]. The data across these studies were heterogenous (Q = 183:855, I 2 = 91:298, p = 0:001), favoring the random effects model. ...
Article
Full-text available
Tribulus terrestris L. (TT) is a traditional medicinal plant, which belongs to the Zygophyllaceae family. TT extracts have been widely used for diuretic, analeptic, aphrodisiac, and profertility properties. To quantitatively evaluate the profertility and aphrodisiac effects of Tribulus terrestris L., we undertook the present meta-analyses on published data. A thorough literature screening was performed to identify articles evaluating the effect of TT on spermatogenesis, male fertility, reproductive, and aphrodisiac parameters. We shortlisted 30 relevant studies conducted on humans and rodents. Meta-analyses were conducted to evaluate the quantitative impact of TT on various fertility parameters. In case of humans, the pooled analysis on 133 subjects showed significant improvements in sperm concentration (SDM = 0:624, 95% CI = 0:13 to 1.117, p = 0:013) and sperm motility (SDM = 0:742, 95% CI = 0:331 to 1.152, p = 0:001). TT resulted in nonsignificant increases in testosterone and LH and a nonsignificant decrease in FSH. Similar to the above, TT improved sperm count, sperm motility, and sperm viability in rodents with normal or compromised fertility. The effect on hormone levels was less credible with frequent variations across studies and animal models. The aphrodisiac activity was studied in castrated animal models or normal rodents, both of which showed significant improvements in mounting frequency and intromission frequency and significant declines in mounting latency and intromission latency. These meta-analyses suggested that TT possesses profertility and aphrodisiac activities.
... the utilization of T. terrestris extract will increase body's ability to create muscle mass and strength and additionally improves circulation and gas transfer [7] . future use of T. terrestris causes dilatation of the vessels and improves coronary arteries while not facet effects [8] . ...
Article
Full-text available
Many different compounds with a spread of biological properties and chemical structures are known from genus Tribulusterrestris together with steroid and terpinoid. In gift study we tend to indicate the preliminary phytochemical analysis for rock oil ether extract and isolated compound. The results unconcealed that there was no alkaloids, supermolecule , glycosides, saponins and tannic acid inpetroleum ether however contain ,steroid and terpinoid. The isolated compound contained solely terpinoid compound. attention procedure was last this compounds. the FTIR qualitative analysis knowledge of isolated compound showed discovered absorptions signal . ultraviolet illumination spectrum showed most absorption at 220 nm due to???*transition that is taken into account as characteristic feature of the unsaturated covalent bond. The concentration of the weather analyzed during this study decrease within the order Fe>Ca>Cu>Zn>Cr. important totally different among microorganism toward T. terrestris oil with p<0.05 and LSD 15.4 ,highest MIC by E.coli about 50 mm in 100% concentration of T. terrestrisoil compared with control.
... T.T. influences metabolism and weight since it contains several ingredients like carbs, glycosides and ascorbic acid [8]. Because it contained 55% furostanol saponins [9]. A number of Tribulus phytochemicals including flavonoid, tannin, and phenolic acids have antioxidant properties, which can prevent oxidative stress, inflammation, apoptosis and the development of a number of illnesses mentioned above [10]. ...
Article
Full-text available
The purpose of the current study was to determine the impact supplementing powdered Tribulus terrestris ( T.T .) seeds on the Red Blood Cells (RBCs) and white blood cells (WBCs) number and hemoglobin (HB), total protein (TP), triglyceride (TG), albumin (ALB) and globulin (GLOB)} levels in the blood, and concentration of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and Testosterone in Awassi lambs. In this study, 32 male Awassi lambs 8-month-old were randomly divided into two groups (each group contains 16 animals). The first group (T1) was given a basal ration plus 3 grams of powdered T.T . seeds per animal per day, while the second group (T2) was given a basal ration only. The period of study was two months. The results revealed that there was a significant effect (P ≤0.05) for (T1) on (T2) in the number of RBCs and HB concentration, also, the results showed that T1greater than T2 in FSH, LH and testosterone concentrations in the blood.
... T. terrestris also known as puncture vine or small caltrops and is used in traditional medicine of India (Ayurveda), China, Bulgaria, Turkey and other countries as strong aphrodisiac, antihypertensive [2], and diuretic [3]. T. terrestris is often used in the treatment of infertility, decreased libido, and erectile dysfunction [4]. It is also used among athletes to increase muscle resistance and improve performance in sports, although scientific evidence to support this effect is scarce [5]. ...
Article
Full-text available
Purpose: To investigate the anti-hyperglycaemic activity of methanol extract of Tribulus terrestris L. Zygophyllaceae in glucose-loaded normal rabbits. Methods: The animals were randomly assigned to 4 groups (n = 5) and treated with a single oral dose. Group 1 served as normal control group and received distilled water; group 2 served as hyperglycaemic control; group 3 was treated with glibenclamide (5 mg/kg, aqueous suspension) and served as reference standard; group 4 received methanol extract of Tribulus terrestris L. (250 mg/kg). Groups 3 and 4 were orally treated with glucose (5 g/kg) after 1 h of drug and extract administration, respectively. Fasting blood glucose (FBG) was determined prior to (0 h) and at 30 min, 1, 2 and 3 h after dosing for acute toxicity study. Results: On comparing within groups, a single dose of the methanol extract of Tribulus terrestris L. lowered FBG to levels comparable to that of glibenclamide (36 vs. 55 %), and reaching the initial level (0 h) at 2 h. FBG were significantly (p < 0.05) lowered at 2 and 3 h in both glibenclamide (45.5 and 56.9 %) and extract (45.7 and 52.7 %) groups as compared with their respective glucose levels at 0.5 h. On the other hand, on comparing between groups, both glibenclamide and methanol extract significantly (p < 0.05, p < 0.001) lowered the rise in blood glucose at 1 h (33.9 and 22.5 %), 2 h (62.8 and 59.16 %), and 3 h (64.6 and 57.1 %) with respect to the hyperglycaemic control group. Conclusion: The methanol extract of the aerial parts of Tribulus terrestris L. possesses potential anti-hyperglycaemic activity in glucose-loaded normal rabbits. Further studies on various organic solvents fractions and isolated compounds from this plant are required.
... Nos estudos realizados por Gauthaman e Ganesan19 e por Ghosian-Moghaddam et al. 20 que avaliavam a disfunção erétil, utilizando animais como ratos, coelhos e primatas, a TT proporcionou um aumento nos níveis de LH (Hormônio Luteinizante), testosterona e seus derivados. Entretanto, pesquisas feitas com humanos para avaliar a força muscular e composição corporal não tiveram resultados tão satisfatórios 18,21 . ...
Article
Objetivo: O presente trabalho tem como finalidade investigar os estudos realizados na literatura, buscando evidências científicas que corroborem o uso dos fitoterápicos citados, com ação anabolizante, atestando seus riscos e benefícios.Método: Trata-se de uma revisão integrativa, utilizando o método PRISMA (Principais Itens para Relatar Revisões Sistemáticas e Meta-análise) como exemplo, onde foram buscados nas bases de dados estudos clínicos em animais e humanos.Resultados e discussão: Verificando as informações obtidas, observou-se que alguns fitoterápicos obtiveram efeito ergogênico positivo elevando os níveis de testosterona livre e força muscular, mas não induziram o aumento de massa corporal magra. Também houve aumento na libido, motilidade e qualidade de esperma, bem como outros efeitos benéficos a saúde. Conclusão: Desta forma, não possuem estudos conclusivos que comprovem a efetividade dos mesmos para o aumento de massa muscular decorrente da indução de produção de testosterona. Mucuna pruriens e Eurycoma longifolia (long jack) obtiveram os melhores resultados no que diz respeito ao efeito ergogênico e testosterona sérica, ainda assim mais ensaios clínicos em humanos são necessários para comprovar sua completa incontestabilidade.
... Similar results were also reported by other researchers who investigated the impact of TT supplement in trained athletes [16,24,27]. Likewise, short-term administration of TT to intact male rats did not change testosterone concentrations during a 4-week period [9,17]. ...
Article
Full-text available
Study aim : To investigate the effect of a 2-week supplementation with Tribulus terrestris L. ( TT ) on the responses of testosterone, cortisol, and thyroid hormones including triiodothyronine (T3) and thyroxine (T4) following an intensive session of resistance exercise (RE). Materials and methods : Twenty-two healthy non-athlete men (23.8 ± 3.1 years) participated in this study were divided into two groups and were randomly assigned to receive either TT supplementation (n = 11) or a placebo (n = 11). They consumed two 250-mg capsules with TT or placebo (maltodextrin) per day and performed six REs with the intensity 80-90% of 1RM on the fifteen day of the experiment. Venous blood samples were drawn before supplementation, and before and after the RE session. Results : The mean values of post-exercise testosterone and cortisol in both groups were significantly higher than pre-exercise and baseline ( p < 0.01); however, there were no significant differences between the groups ( p > 0.05). Likewise, despite a trend toward different levels of the responses of thyroid hormones with TT supplementation, there were no significant differences either in different time points or the groups ( p > 0.05). Conclusions : Short-term supplementation with TT appears to be ineffective in changing the hormonal responses measured in this study following a session of high-intensity RE.
Conference Paper
Full-text available
Tribulus terrestris L. (TT) has been used since ancient times to energize the body and to stimulate and improve sexual function. Plant products from TT continue to be widely used nowadays to improve health, sports results and also sexual desire and performance. The current medical data is still insufficient to firmly support or reject the use of TT for such purposes. Traditionally, steroid saponins from the plant are considered to be the main biologically active substances. The initial assumption was that steroid saponins are metabolized into sex hormones by the body. Unfortunately, further studies have failed to confirm significant and consistent changes in the levels of sex hormones. Regarding the aphrodisiac effects, the clinical trials conducted in recent years have shown more promising results. Suggested mechanisms of action are based on an improved endothelial function, potentiation of nitric oxide and possible CNS mechanisms resulting in increased sexual desire.
Article
Abnormal uterine bleeding (AUB) is the most common gynecological problem and is often accompanied with uterine fibroid. Very limited options are available in biomedicine for the AUB. In this reported case, AUB associated with stasis dermatitis was managed on the line of treatment of Vataja Yonivyapada with satisfactory results. This is a case of AUB in uterine fibroid associated with stasis dermatitis in the left lower limb of a 39-year-old female. Gokshuradi Guggulu 750 mg, Shatavari Churna - 2 g, Gairika - 500 mg, and Mukta Shukti Pishti - 500 mg were given twice a day for 18 months, Pushyanuga Churna - 2 g, Chandraprabha Vati - 250 mg, and Arsha Kuthara Rasa 250 mg twice a day for 8 months, and Gokshura churna - 2 g twice a day for 14 months were given to her as oral medication. Jatyadi taila was applied locally twice a day on affected area for 17 months. Four sets of Anuvasana Basti (medicated oil enema), one set of Raktamokshana (therapeutic bloodletting) with Alabu , and three sets of Raktamokshana with Shringa were also adopted in 14 months of treatment duration. After 14 months of treatment, the size of the bulky uterus was reduced from 108 mm × 76 mm × 70 mm in May 2018 to 102 mm × 64 mm × 55 mm in May 2019 and from 7.0 to 6.6 mm in endometrium thickness. The fibroid was resolved, and abnormal bleeding was arrested. This case demonstrates that Ayurveda oral medication and Panchakarma based on the management of Vataja Yonivyapada may be useful in AUB associated with stasis dermatitis.
Article
Full-text available
Tribulus terrestris, puncture vine has long been used in traditional medicine to treat impotency and improve sexual functions in man although, there are little information about effect of Tribulus terrestris on female reproduction. The objective of the present study was to investigate the effect of Tribulus trestris extract on ovarian activity of immature wistar rat. About 20 immature female wistar rats, aged 21 days and with an average weight of 50 g were used in the study. The rats randomly divided into treatment and control groups. Rats in treatment group received 10 mg of the extract per rat. The period of the study divided into 7 and 14 days period. Half of the rats in each group (n = 5) were euthanized at final day of each period and the ovaries removed for preparating of histology sections. Number and diameter of corpus luteum, thickness of theca interna layer and number of all follicles were evaluated in each left and right ovaries. Results showed that number of corpus luteum and diameter of theca interna increased in treatment group as compared with control group. Number of secondly and graafian follicles after 14 days treatment were be higher than control and 7 days treatment. The present results indicated that Tribulus terrestris induces corpus luteum formation and growth and therefore beginning of puberty with its LH-like activity.
Article
Full-text available
Morphine and lidocaine are known to influence the perception of pain. The present study sought to determine the influence of local administration of morphine on lidocaine-induced analgesia in morphine non-dependent (MND), morphine dependent (MD) and morphine withdrawal (MW) animals. Adult male Wistar rats were divided into four groups: Control, MND, MD and MW rats. Lidocaine (0.5, 1 and 2%) and morphine (200, 400 and 800 µg) were injected in the plantar surface of the right paw. MD animals received chronic oral morphine (0.1, 0.2, 0.3 and 0.4 mg/ml in their drinking water) for 20 days. Twenty four hours before experiment, the animals in the MW group were deprived of morphine in their drinking water (physical dependence was observed by precipitating an abstinence syndrome with naloxone 2 mg/kg i.p.). Analgesia was assessed using hot-plate apparatus. Morphine (400 µg) and lidocaine (2%) produce local analgesia in MND group. In MND rats, non-analgesic doses of each drug (200 µg morphine and 1% lidocaine) were used in combination and produced analgesia. In MD animals, all doses of lidocaine produced analgesia, while in MW animals, it failed to produce analgesia. In this situation, local administration of morphine could eventually influence the analgesic effect of lidocaine. Opioid withdrawal is one of the most common problems in clinic. This study determined the analgesic effect of lidocaine in MW animals in which lidocaine had no analgesic effect. In this regard, local administration of morphine with combination of lidocaine could probably produce an effective analgesia.
Article
Full-text available
Contents The objective of this study was to investigate the effects of a preparation from herbal extracts (PHE) on libido and semen quality in breeding artificial insemination boars. Ten fertile boars were divided into control and experimental groups according to significant difference of libido. There were no differences in semen quality between groups. Animals were fed a commercial feeding mixture for boars. The feeding mixture for the experimental group was enriched with PHE, which was prepared from Eurycoma longifolia , Tribulus terrestris and Leuzea carthamoides . Duration of the experiment was 10 weeks. Samples of ejaculate were collected weekly. Libido was evaluated according to a scale of 0–5 points. Semen volume, sperm motility, percentage of viable spermatozoa, sperm concentration, morphologically abnormal spermatozoa, daily sperm production and sperm survival were assessed. Amounts of mineral components and free amino acids were analysed in seminal plasma. Significant differences were found in these parameters: libido (4.05 ± 0.22 vs 3.48 ± 0.78; p < 0.001), semen volume (331.75 ± 61.91 vs 263.13 ± 87.17 g; p < 0.001), sperm concentration (386.25 ± 107.95 vs 487.25 ± 165.50 × 10 ³ /mm ³ ; p < 0.01), morphologically abnormal spermatozoa (15.94 ± 11.08 vs 20.88 ± 9.19%; p < 0.001) and Mg concentration (28.36 ± 11.59 vs 20.27 ± 13.93 m m ; p < 0.05). The experimental group’s libido was increased by 20% in comparison with the beginning of the experiment. Results of this study showed positive effect of PHE on libido and some parameters of boar semen quality.
Article
Full-text available
In the present retrospective investigation, the long-term effects of continuous intrathecal opioid therapy via implantable infusion pump systems were examined in 120 patients with chronic, nonmalignant pain syndromes. The follow-up period was 6 months to 5.7 years (mean 3.4 years +/- 1.3 standard error of the mean). Deafferentation pain and neuropathic pain showed the best long-term results, with 68% and 62% pain reduction (visual analog scale), respectively. The mean morphine dosage initially administered was 2.7 mg/day (range 0.3-12 mg/day); after an average of 3.4 years, it was 4.7 mg/day (range 0.3-12 mg/day). In a long-term observation of 28 patients who received intrathecal morphine for longer than 4 years. 18 patients (64.3%) had a constant dosage history and 10 patients (35.7%) showed an increase in morphine dosage to more than 6 mg/day 1 year after dosage determination. In seven cases, a tolerance developed: in four patients the tolerance was controlled by means of "drug holidays"; but in three patients it was necessary to remove the pump systems. Explantation of the pump system occurred in 22 additional cases for other reasons. Throughout the follow-up period, 74.2% of the patients profited from the intrathecal opiate therapy: the average pain reduction after 6 months was 67.4% and, as of the last follow-up examination, it was 58.1%. Ninety-two percent of the patients were satisfied with the therapy and 81% reported an improvement in their quality of life. The authors' 6-year experience with administration of intrathecal opioid medications for nonmalignant pain should encourage the use of this method in carefully selected patients.
Article
Full-text available
Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role of opioids in endocrine regulation, few data are available about possible effects on hypothalamic-pituitary function during this treatment. Seventy-three patients (29 men and 44 women; mean age, 49.2 ± 11.7 yr) receiving opioids intrathecally for nonmalignant pain were enrolled for extensive endocrine investigation. At the time of hormonal determination, the mean duration of opioid treatment was 26.6 ± 16.3 months; the mean daily dose of morphine was 4.8 ± 3.2 mg. The control group consisted of 20 patients (11 men and 9 women; mean age, 54.2 ± 14.0 yr) with a comparable pain syndrome but not treated with opioids. Decreased libido or impotency was present in 23 of 24 men receiving opioids. The serum testosterone level was below 9 nmol/L in 25 of 29 men and was significantly lower than that in the control group (P < 0.001). The free androgen index was below normal in 18 of 29 men and was significantly lower than that in the control group (P < 0.001). The serum LH level was less than 2 U/L in 20 of 29 men and was significantly lower than that in the control group (P < 0.001). Serum FSH was comparable in both groups. Decreased libido was present in 22 of 32 women receiving opioids. All 21 premenopausal females developed either amenorrhea or an irregular menstrual cycle, with ovulation in only 1. Serum LH, estradiol, and progesterone levels were lower in the opioid group. In all 18 postmenopausal females significantly decreased serum LH (P < 0.001) and FSH (P = 0.012) levels were found. The 24-h urinary free cortisol excretion was below 20 μg/day in 14 of 71 opioid patients and was significantly lower than that in the control group (P = 0.003). The peak cortisol response to insulin-induced hypoglycemia was below 180 μg/L in 9 of 61 opioid patients and was significantly lower than that in the nonopioid group (P = 0.002). The insulin-like growth factor I sd score was below −2 sd in 12 of 73 opioid patients and was significantly lower than that in the control group (P = 0.002). The peak GH response to hypoglycemia was below 3 μg/L in 9 of 62 subjects and was significantly lower than that in the control group (P = 0.010). Thyroid function tests and PRL levels were considered normal. No metabolic disturbances were recorded, apart from significantly decreased high density lipoprotein cholesterol levels (P = 0.041) and elevated total/high density lipoprotein cholesterol ratio (P = 0.008) in the opioid group compared to the control group. Supplementation with gonadal steroids improved sexual function in most patients. In conclusion, of all patients receiving intrathecal opioids, the large majority of men and all women developed hypogonadotropic hypogonadism, about 15% developed central hypocorticism, and about 15% developed GH deficiency. These findings suggest that further investigations are required to determine the need for systematic endocrine work-up in these patients and the necessity for substitutive therapy.
Article
Full-text available
The purpose of this study was to determine the effects of the herbal preparation Tribulus terrestris (tribulus) on body composition and exercise performance in resistance-trained males. Fifteen subjects were randomly assigned to a placebo or tribulus (3.21 mg per kg body weight daily) group. Body weight, body composition, maximal strength, dietary intake, and mood states were determined before and after an 8-week exercise (periodized resistance training) and supplementation period. There were no changes in body weight, percentage fat, total body water, dietary intake, or mood states in either group. Muscle endurance (determined by the maximal number of repetitions at 100-200% of body weight) increased for the bench and leg press exercises in the placebo group (p <.05; bench press +/-28.4%, leg press +/-28.6%), while the tribulus group experienced an increase in leg press strength only (bench press +/-3.1%, not significant; leg press +/-28.6%, p <.05). Supplementation with tribulus does not enhance body composition or exercise performance in resistance-trained males.
Article
This paper provides a comprehensive list of about 472 authentic vegetable crude drug samples belonging to about 375 plant species that are housed in the Crude Drug Museum (CDM) of Pharmacognosy Section, Botanical Survey of India (BSI), Howrah. This museum is a repository of raw drug samples or vegetable crude drug samples such as rhizomes, roots, stems, wood, bark, leaves, flowers, fruits, seeds etc. that are commonly used in the Indian Systems of Medicine (ISM). It provides a baseline information on these raw drugs. The various uses of this museum have been highlighted in this paper.
Article
Female sexual dysfunction (FSD) is a complex and multifactorial condition. An increased incidence of FSD is especially associated with the decline of estrogen. Thus, menopause is a critical phase for FSD complaints. In this context, medicinal plants may be a therapeutic option. To identify and describe the popular and clinical uses of medicinal plants for FSD treatment in climacteric women. We highlighted the majority of the plants commonly involved with the female reproductive system including: Angelica sinensis, Cimicifuga racemosa, Ferula hermonis, Ginkgo biloba, Humulus lupulus, Lepidium meyenii, Tribulus terrestris, Trifolium pratense, and Vitex agnus-castus. This study is a narrative review of studies of plants that are possible alternative treatments for FSD. The species described have clinical and popular uses in different cultures as well as medical indications for female reproductive disturbances, mainly in climacteric women. We have also analyzed the evidence level of clinical studies. The main outcome assessed is the efficacy of plants in improving the symptoms of FSD. There is little evidence from the literature to recommend the use of medicinal plants when treating FSD. The majority of studies with a strong level of evidence are associated with the treatment of the vasomotor symptoms of menopause. Ferula hermonis, Angelica sinensis, and Gingko biloba may be suggested for arousal disorder studies. Cimicifuga racemosa, Trifolium pratense, and Vitex agnus-castus may be recommended for several FSD. Humulus lupulus and Tribulus terrestris may help with desire disorder studies. Lepidium meyenii should be studied further. Studies of these plants indicate that they may be useful as a possible alternative and/or complementary approach for studies aimed at the treatment of FSD. At this time, however, this review cannot recommend a plant that has a strong enough level of evidence for treatment of FSD. Thus, there is a need for clinical (double-blinded and randomized) studies to evaluate the efficacy and safety of several plants that can exert a positive effect on the management of FSD.
Article
Seven plants and a herbal mixture used for traditional treatment of diabetes were studied in streptozotocin diabetic mice. The treatments were supplied as 6.25% by weight of the diet for 9 days. Consumption of diets containing bearberry (Arctostaphylos uva-ursi), golden seal (Hydrastis canadensis), mistletoe (Viscum album) and tarragon (Artemisia dracunculus) significantly reduced the hyperphagia and polydipsia associated with streptozotocin diabetes, but bayberry (Cinnamomum tamala), meadowsweet (Filipendula ulmaria), senna (Cassia occidentalis) and the herbal mixture did not alter these parameters. Bearberry, mistletoe and tarragon retarded the body weight loss but none of the eight treatments significantly altered plasma glucose or insulin concentrations. These studies suggest that bearberry, golden seal, mistletoe and tarragon may counter some of the symptoms of streptozotocin diabetes without, however, affecting glycemic control.
Article
Altered sexual function has been reported in individuals addicted to opioids or on methadone maintenance, yet little literature is available regarding the effect of intraspinal opioids on libido or sex hormone levels. We evaluated sexual function and plasma sex hormone levels in six men treated with chronic intraspinal opioids. All patients had some reduction in libido and four patients had difficulty obtaining or maintaining an erection. These changes were noted within 1 month of beginning intraspinal opioid therapy. Serum testosterone levels ranged from 26 to 367 ng/dL (normal, 350-1500 ng/dL); the mean serum level was 197.7 ng/dL (SD = 119.8). Serum testosterone levels and other sex hormones, including follicle-stimulating hormone, luteinizing hormone, sex-hormone-binding globulin, and prolactin, should be measured prior to and at various points during intraspinal opioid therapy. Patients should be queried regarding sexual function and should be cautioned regarding the possibility of these adverse effects prior to initiating spinal opioids. Supplemental testosterone should be considered to treat this dysfunction.